Geode Capital Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,050,757
| Closed | -$89.3M | – | 4281 |
|
|
2019
Q4 | $89.3M | Buy |
1,050,757
+46,525
| +5% | +$3.1M | 0.02% | 657 |
|
|
2019
Q3 | $50.2M | Buy |
1,004,232
+96,736
| +11% | +$3.86M | 0.01% | 880 |
|
|
2019
Q2 | $33.1M | Buy |
907,496
+72,103
| +9% | +$2.35M | 0.01% | 1135 |
|
|
2019
Q1 | $23.3M | Buy |
835,393
+45,229
| +6% | +$1.07M | 0.01% | 1311 |
|
|
2018
Q4 | $15.1M | Buy |
790,164
+70,001
| +10% | +$1.63M | ﹤0.01% | 1470 |
|
|
2018
Q3 | $21.5M | Buy |
720,163
+36,764
| +5% | +$1.39M | 0.01% | 1355 |
|
|
2018
Q2 | $25.1M | Buy |
683,399
+42,833
| +7% | +$1.39M | 0.01% | 1195 |
|
|
2018
Q1 | $21.1M | Buy |
640,566
+7,493
| +1% | +$234K | 0.01% | 1223 |
|
|
2017
Q4 | $17.3M | Buy |
633,073
+42
| +0% | +$1.29K | 0.01% | 1363 |
|
|
2017
Q3 | $23.4M | Sell |
633,031
-1,277
| -0.2% | -$47.1K | 0.01% | 1122 |
|
|
2017
Q2 | $24.1M | Buy |
634,308
+27,480
| +5% | +$1.22M | 0.01% | 1050 |
|
|
2017
Q1 | $29.7M | Buy |
606,828
+47,109
| +8% | +$2.15M | 0.01% | 891 |
|
|
2016
Q4 | $19M | Buy |
559,719
+22,690
| +4% | +$805K | 0.01% | 1123 |
|
|
2016
Q3 | $20.3M | Buy |
537,029
+37,745
| +8% | +$1.42M | 0.01% | 987 |
|
|
2016
Q2 | $16.8M | Buy |
499,284
+13,455
| +3% | +$474K | 0.01% | 1059 |
|
|
2016
Q1 | $15.4K | Buy |
485,829
+21,756
| +5% | +$711K | 0.01% | 1085 |
|
|
2015
Q4 | $17.3M | Buy |
464,073
+22,115
| +5% | +$836K | 0.01% | 988 |
|
|
2015
Q3 | $16.8M | Buy |
441,958
+12,737
| +3% | +$447K | 0.01% | 988 |
|
|
2015
Q2 | $12.3M | Buy |
429,221
+21,820
| +5% | +$608K | 0.01% | 1259 |
|
|
2015
Q1 | $11.4M | Buy |
407,401
+19,510
| +5% | +$548K | 0.01% | 1286 |
|
|
2014
Q4 | $10.7M | Buy |
387,891
+6,816
| +2% | +$169K | 0.01% | 1275 |
|
|
2014
Q3 | $8.51M | Buy |
381,075
+1,295
| +0.3% | +$32.9K | 0.01% | 1390 |
|
|
2014
Q2 | $11M | Buy |
379,780
+4,661
| +1% | +$124K | 0.01% | 1230 |
|
|
2014
Q1 | $10.7M | Sell |
375,119
-6,969
| -2% | -$231K | 0.01% | 1211 |
|
|
2013
Q4 | $14.8M | Buy |
382,088
+75,930
| +25% | +$2.72M | 0.01% | 943 |
|
|
2013
Q3 | $10.3M | Buy |
306,158
+78,183
| +34% | +$2.49M | 0.01% | 1048 |
|
|
2013
Q2 | $7.01M | Buy |
+227,975
| New | +$7.63M | 0.01% | 1192 |
|
Other funds holding MDCO
Geode Capital Management's MDCO Position: Q1 2020 in Review
Geode Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,050,757 shares — an estimated $89.3M sold.
Geode Capital Management first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $89.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Geode Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Geode Capital Management sold 1,050,757 Medicines Co shares in Q1 2020, an estimated $89.3M.
- Geode Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Geode Capital Management's Medicines Co position peaked at $89.3M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.